-+ 0.00%
-+ 0.00%
-+ 0.00%

Red Light Holland FY26 EBITDA loss widens to CAD 6.75 million; revenue falls 15.15% to CAD 4.2 million

PUBT·07/29/2026 11:54:19
Listen to the news
Red Light Holland FY26 EBITDA loss widens to CAD 6.75 million; revenue falls 15.15% to CAD 4.2 million
  • Red Light Holland posted fiscal 2026 revenue of CAD 4.2 million, down 15.15%.
  • EBITDA loss widened to CAD 6.75 million; gross profit slipped 16.84% to CAD 1.59 million.
  • Cash fell to CAD 8.47 million; total assets dropped to CAD 14.57 million.
  • Completed the Filament Health acquisition, adding 76 issued patents and a Phase II-ready botanical psilocybin candidate, PEX010.
  • Rebrand to Rhelion Life Sciences expected Aug. 4, 2026; RLH Netherlands sold SR Wholesale for EUR 150,000 cash.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Red Light Holland Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607290753NEWSFILECNPR____20260729_307092_1) on July 29, 2026, and is solely responsible for the information contained therein.